From: Disseminated carcinomatosis of the bone marrow from pancreatic cancer: a case report
Variable | On Admission | Two Weeks after Presentaion |
---|---|---|
White blood cell count (per mm3) | 11100 | 12100 |
Differential count (%) | ||
Neutrophils | 73 | |
Lymphocytes | 15 | |
Monocytes | 9 | |
Eosinophils | 0 | |
Basophils | 0 | |
Myelocytes | 3 | 5.0 |
Metamyelocyte | 0 | 1.0 |
Hemoglobin (g/dL) | 15.0 | 14.5 |
Hematocrit (%) | 42.6 | |
Platelet count (per mm3) | 73000 | 75000 |
international normalized ratio for prothrombin time | 1.15 | 2.14 |
Activated partial-thromboplastin time (sec) | 29.8 | 41.7 |
Fibrinogen (mg/dL) | 102 | 150 |
Fibrin degradation products (μg/mL) | 65.7 | 98.8 |
D-dimer (μg/mL) | 18.1 | 34.7 |
Antithrombin- III activity (%) | 61 | |
C reactive protein (mg/dL) | 3.63 | 8.56 |
Total protein (g/dL) | 7.1 | |
Albumin (g/dL) | 4.2 | 3.8 |
Blood urea nitrogen (mg/dL) | 27 | 36 |
Creatinine (mg/dL) | 1.32 | 1.44 |
Sodium (mEq/L) | 143 | |
Potassium (mEq/L) | 3.3 | |
Chloride (mEq/L) | 104 | |
Calcium (mg/dL) | 11.3 | |
Total bilirubin (mg/dL) | 1.2 | |
Direct bilirubin (mg/dL) | 0.5 | |
Asparate aminotransferase (U/L) | 164 | |
Alanine aminotransferase (U/L) | 119 | |
Alkaline phosphatase (U/L) | 547 | 1012 |
Lactate dehydrogenase (U/L) | 552 | 608 |
Carcinoembryonic antigen (ng/mL) | 23.6 | |
Carbohydrate antigen 19-9 (U/mL) | 72836 | |
Span-1 (U/mL) | 5200 | |
DUPAN-2 (U/mL) | 440 |